证券记录 · 已归档季度
SMMT
Summit Therapeutics Inc. · Healthcare · Biotechnology
14被追踪持有人
0Δ持有人
38.14M持有股份
$811.62M报告持仓市值
+1新建仓位
−1清仓
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 -11.4% · 净新建仓位 0.0% · 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | +1 | 125.39K | $2.14M | +1 | n/a |
| Q2 2026 | 86 | +5 | 84.30M | $1.23B | +8 | −2 |
| Q1 2026 | 82 | +1 | 68.40M | $1.29B | +10 | −10 |
| Q4 2025 | 81 | 0 | 72.69M | $1.27B | +1 | n/a |
| Q3 2025 | 15 | -1 | 45.07M | $931.26M | +1 | −3 |
| Q2 2025 | 14 | 0 | 38.14M | $811.62M | +1 | −1 |
| Q1 2025 | 11 | +1 | 18.29M | $352.78M | +1 | n/a |
| Q4 2024 | 10 | +1 | 17.85M | $318.58M | +1 | n/a |
| Q3 2024 | 8 | 0 | 10.94M | $239.67M | +1 | −1 |
| Q2 2024 | 8 | n/a | 7.47M | $58.27M | n/a | n/a |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 9.23M | n/a | $196.34M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 2 | The Vanguard Group ✦ (被动) | 8.67M | n/a | $184.58M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 3 | BlackRock ✦ (被动) | 6.85M | n/a | $145.70M | 0.0% | n/c | 1 | SEC ↗ ×12 |
| 4 | State Street Global Advisors ✦ (被动) | 4.02M | -17.2% | $85.50M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 3.91M | -40.5% | $83.10M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 6 | Geode Capital Management ✦ (被动) | 2.93M | -10.7% | $62.47M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 7 | Norges Bank ✦ (被动) | 1.39M | +36.5% | $29.58M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | Millennium Management ✦ | 556.01K | -37.3% | $11.83M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 9 | Marshall Wace ✦ | 271.64K | 新增 | $5.78M | 0.0% | New | 1 | SEC ↗ ×2 |
| 10 | D. E. Shaw & Co. ✦ | 137.44K | +361.6% | $2.92M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 11 | Citadel Advisors ✦ | 102.42K | -89.8% | $2.18M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 12 | Wellington Management ✦ | 39.69K | -2.0% | $844,689 | 0.0% | ▼ Trim | 5 | SEC ↗ ×4 |
| 13 | AQR Capital Management ✦ | 22.31K | -66.0% | $474,799 | 0.0% | ▼ Trim | 5 | SEC ↗ ×3 |
| 14 | Gotham Asset Management ✦ | 15.73K | -0.3% | $334,713 | 0.0% | ▼ Trim | 5 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Marshall Wace | $5.78M | 0.0% |
已清仓
| Adage Capital Partners | $10.38M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 223 持有人, 118.88M 股份, $2.10B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据